Cell-Based Glioma Models for Anticancer Drug Screening: From Conventional Adherent Cell Cultures to Tumor-Specific...

Area of Science:

• Neuro-oncology
• Cancer Biology
• Drug Discovery

Background:

• Gliomas are aggressive primary brain tumors with poor prognoses.
• Treatment is limited by tumor infiltration, heterogeneity, and the blood-brain barrier.
• Current therapies, like alkylating agents, have variable efficacy based on glioma subtypes.

Purpose of the Study:

• To review existing glioma cell-based models for drug screening.
• To identify limitations of current models in replicating tumor microenvironments.
• To propose future directions for comprehensive and personalized glioma drug discovery.

Main Methods:

• Analysis of existing literature on glioma cell-based models.
• Comparison of 2D cell cultures with more advanced in vitro models.
• Evaluation of model suitability for predicting therapeutic response.

Main Results:

• Standard 2D cell cultures inadequately mimic in vivo glioma conditions.
• Existing models present both advantages and disadvantages for drug screening.
• Improved models are crucial for advancing therapeutic development.

Conclusions:

• There is a critical need for improved glioma cell models.
• Advanced models can enhance the effectiveness of drug discovery pipelines.
• Personalized therapy paradigms require better preclinical models for gliomas.